David Arkowitz - 10 May 2021 Form 4 Insider Report for Flexion Therapeutics Inc

Signature
/s/ Mark S. Levine, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
10 May 2021
Net transactions value
-$16,116
Form type
4
Filing time
12 May 2021, 17:06:20 UTC
Previous filing
09 Mar 2023
Next filing
01 Jun 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLXN Common Stock Sale $16,116 -2,229 -1% $7.23 220,719 10 May 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover tax withholding obligations associated with the vesting of a restricted stock unit award granted to the Reporting Person on June 1, 2018.
F2 The weighted average sale price for the transaction reported was $7.23. The shares were sold at a range of prices between $7.14 and $7.23. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.